This is a routine investor presentation update with no new financial data or guidance. Monitor for future 10-Q filings to assess revenue traction and test volume growth.
Price Chart
Executive Summary
Cardio Diagnostics Holdings, Inc. filed an 8-K with an investor presentation deck. The presentation highlights its AI-powered epigenetic blood tests (Epi+Gen CHD and PrecisionCHD) for cardiovascular disease, a $175B+ TAM, CMS final payment rate of $854 per test, and progress on reimbursement milestones. No financial results or guidance were provided, making this a routine business update with no material new information for traders.
Key Facts
- Filed an 8-K with an August 2026 investor presentation (Exhibit 99.1).
- Presentation claims a $175B+ total addressable market across Epi+Gen CHD and PrecisionCHD tests.
- CMS final payment rate set at $854 per test for both CPT PLA codes (0439U and 0440U) in December 2025.
- Company-owned CLIA lab is operational, with initial COGS reduction of ~30% and target ~40% gross margin at scale.
- No financial results, guidance, or preliminary metrics were disclosed in the filing.
Financial Impact
No financial figures reported in the filing.
Risk Factors
- Pre-revenue or early-revenue stage with no disclosed financial results.
- Reimbursement and commercial adoption are still in early stages; Medicare coverage determination is in progress.
- Micro-cap stock ($6M market cap) with limited liquidity and high volatility.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001079973-26-001153 |
| Document: cdio_8k.htm | 0001079973-26-001153 |
| Document: 0001079973-26-001153-index-headers.html | 0001079973-26-001153 |
| Document: 0001079973-26-001153-index.html | 0001079973-26-001153 |
| Document: 0001079973-26-001153.txt | 0001079973-26-001153 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 20, 2026 9w ago | 8-K | $2.21 $2.02 | ▼ −8.60% | ▼ −8.60% | $1.72 (−22.17%) |
Aug 7, 2026 11w ago | DEFA14A | $1.79 $1.86 | ▲ +3.91% | ▲ +4.31% | $1.72 (−3.91%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers